SUNLINK HEALTH SYSTEMS INC SSY

expiry = 2020-01-31EX-99.(A)(1)(A) 2 d819936dex99a1a.htm EXHIBIT (A)(1)(A) Exhibit (a)(1)(A) Exhibit (a)(1)(A) SUNLINK HEALTH SYSTEMS, INC. Notice of Share Repurchase Program THE SHARE REPURCHASE PROGRAM WILL EXPIRE AT 4:00 P.M., NEW YORK CITY TIME, ON JANUARY 31, 2020, UNLESS THE PROGRAM IS EXTENDED OR EARLIER TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED OR TERMINATED, THE “EXPIRATION TIME”). SunLink Health Systems, Inc., an Ohio corporation (the “Company,” “SunLink,” “we,” “our” or “us”), is pleased to...

expiry = 2020-01-31EX-99.(A)(3)(A) 2 d824128dex99a3a.htm EXHIBIT (A)(3)(A) Exhibit (a)(3)(A) Exhibit (a)(3)(A) SUNLINK HEALTH SYSTEMS, INC. Notice of Share Repurchase Program THE SHARE REPURCHASE PROGRAM WILL EXPIRE AT 4:00 P.M., NEW YORK CITY TIME, ON JANUARY 31, 2020, UNLESS THE PROGRAM IS EXTENDED OR EARLIER TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED OR TERMINATED, THE “EXPIRATION TIME”). SunLink Health Systems, Inc., an Ohio corporation (the “Company,” “SunLink,” “we,” “our” or “us”), is pleased to...

expiry = 2020-01-31EX-99.(A)(3)(A) 2 d824128dex99a3a.htm EXHIBIT (A)(3)(A) Exhibit (a)(3)(A) Exhibit (a)(3)(A) SUNLINK HEALTH SYSTEMS, INC. Notice of Share Repurchase Program THE SHARE REPURCHASE PROGRAM WILL EXPIRE AT 4:00 P.M., NEW YORK CITY TIME, ON JANUARY 31, 2020, UNLESS THE PROGRAM IS EXTENDED OR EARLIER TERMINATED (SUCH TIME, AS IT MAY BE EXTENDED OR TERMINATED, THE “EXPIRATION TIME”). SunLink Health Systems, Inc., an Ohio corporation (the “Company,” “SunLink,” “we,” “our” or “us”), is pleased to...

listed = True...m. Purchases of shares under the Program are, however, subject to certain terms and conditions including, in the case of open market purchases on behalf of the Company, settlement of the applicable transaction in the ordinary course. See Section 7. Our shares are listed on the NYSE American, LLC stock exchange (the “NYSE American Exchange”) and trade under the symbol “SSY.” On October 14, 2019, the reported closing price of our shares on the NYSE American Exchange was $1.15 per share. On October 7, 2019, the last full trading day prior to the announcement of the Program, the reported closing price of our shares on...

listed = True...m. Purchases of shares under the Program are, however, subject to certain terms and conditions including, in the case of open market purchases on behalf of the Company, settlement of the applicable transaction in the ordinary course. See Section 7. Our shares are listed on the NYSE American, LLC stock exchange (the “NYSE American Exchange”) and trade under the symbol “SSY.” On October 24, 2019, the reported closing price of our shares on the NYSE American Exchange was $1.17 per share. On October 7, 2019, the last full trading day prior to the announcement of the Program, the reported closing price of our shares on...

listed = True...m. Purchases of shares under the Program are, however, subject to certain terms and conditions including, in the case of open market purchases on behalf of the Company, settlement of the applicable transaction in the ordinary course. See Section 7. Our shares are listed on the NYSE American, LLC stock exchange (the “NYSE American Exchange”) and trade under the symbol “SSY.” On October 25, 2019, the reported closing price of our shares on the NYSE American Exchange was $1.14 per share. On October 7, 2019, the last full trading day prior to the announcement of the Program, the reported closing price of our shares on...

mechanism = FIXED...cted in light of: (1) the lack of interest by odd-lot holders in an odd-lot tender offer commenced in February 2013 for odd lot shares, which was open to holders of odd lots only, and was completed in March 2013, resulting in the purchase of 2,705 shares at a purchase price of $1.50 per share plus a $100 bonus for each tender for an aggregate purchase price of $10,858 (the “2013 Odd Lot Offer”); (2) the relative lack of interest in a tender offer commenced in January 2017 for 3,000,000 shares, which was open to all holders and was completed in February 2017, resulting in the purchase of only 280,800 shares at a purchase price...

mechanism = FIXED...cted in light of: (1) the lack of interest by odd-lot holders in an odd-lot tender offer commenced in February 2013 for odd lot shares, which was open to holders of odd lots only, and was completed in March 2013, resulting in the purchase of 2,705 shares at a purchase price of $1.50 per share plus a $100 bonus for each tender for an aggregate purchase price of $10,858 (the “2013 Odd Lot Offer”); (2) the relative lack of interest in a tender offer commenced in January 2017 for 3,000,000 shares, which was open to all holders and was completed in February 2017, resulting in the purchase of only 280,800 shares at a purchase price...

mechanism = FIXED...cted in light of: (1) the lack of interest by odd-lot holders in an odd-lot tender offer commenced in February 2013 for odd lot shares, which was open to holders of odd lots only, and was completed in March 2013, resulting in the purchase of 2,705 shares at a purchase price of $1.50 per share plus a $100 bonus for each tender for an aggregate purchase price of $10,858 (the “2013 Odd Lot Offer”); (2) the relative lack of interest in a tender offer commenced in January 2017 for 3,000,000 shares, which was open to all holders and was completed in February 2017, resulting in the purchase of only 280,800 shares at a purchase price...

price = USD 0.71-2.09...ember 30, 2019, 595,000 shares were issuable pursuant to outstanding awards of options (all of which were fully vested and exercisable as of such date); at exercise prices ranging from $0.71 to $2.09 per share which have been issued under applicable equity award plans. The following table sets forth, as of September 23, 2019 (unless otherwise indicated in the footnotes), certain information with respect to our shares reported...

price = USD 0.71-2.09...ember 30, 2019, 595,000 shares were issuable pursuant to outstanding awards of options (all of which were fully vested and exercisable as of such date); at exercise prices ranging from $0.71 to $2.09 per share which have been issued under applicable equity award plans. The following table sets forth, as of September 23, 2019 (unless otherwise indicated in the footnotes), certain information with respect to our shares reported...

price = USD 0.71-2.09...ember 30, 2019, 595,000 shares were issuable pursuant to outstanding awards of options (all of which were fully vested and exercisable as of such date); at exercise prices ranging from $0.71 to $2.09 per share which have been issued under applicable equity award plans. The following table sets forth, as of September 23, 2019 (unless otherwise indicated in the footnotes), certain information with respect to our shares reported...

txn_type = CONSOLIDATION...lders and the potential impact of such alternatives on the ability of the Company to go private including: (1) a share repurchase program; (2) a tender offer, open to either holders of odd lots (less than 100 shares) or all holders; (3) a cash dividend; (4) a reverse stock split; (5) a cash-out merger; and (6) a reclassification of shares. A tender offer was considered and rejected in light of: (1) the lack of interest by odd-lot holders in an odd-lot tender offer commenced in February 2013 for odd lot shares, which was open to holders of odd lots only, and was completed in March 2013, resulting in the purchase...

txn_type = CONSOLIDATION...lders and the potential impact of such alternatives on the ability of the Company to go private including: (1) a share repurchase program; (2) a tender offer, open to either holders of odd lots (less than 100 shares) or all holders; (3) a cash dividend; (4) a reverse stock split; (5) a cash-out merger; and (6) a reclassification of shares. A tender offer was considered and rejected in light of: (1) the lack of interest by odd-lot holders in an odd-lot tender offer commenced in February 2013 for odd lot shares, which was open to holders of odd lots only, and was completed in March 2013, resulting in the purchase...

txn_type = CONSOLIDATION...lders and the potential impact of such alternatives on the ability of the Company to go private including: (1) a share repurchase program; (2) a tender offer, open to either holders of odd lots (less than 100 shares) or all holders; (3) a cash dividend; (4) a reverse stock split; (5) a cash-out merger; and (6) a reclassification of shares. A tender offer was considered and rejected in light of: (1) the lack of interest by odd-lot holders in an odd-lot tender offer commenced in February 2013 for odd lot shares, which was open to holders of odd lots only, and was completed in March 2013, resulting in the purchase...